Viewing

Phase I and Biomarker Study of OPB-51602, a Novel Signal Transducer and Activator of Transcription (STAT) 3 Inhibitor, in Patients with Refractory Solid Malignancies (Ann Oncol, May 2015)

References Wong AL1, Soo RA1, Tan DS2, Lee SC1, Lim JS3, Marban PC4, Kong LR5, Lee YJ5, Wang LZ6, Thuya WL5, Soong R5, Yee MQ5, Chin TM1, Cordero MT4, Asuncion BR5, Pang B5, Pervaiz S7, Hirpara JL5, Sinha A8, Xu WW9, Yuasa M10, Tsunoda T10, Motoyama M10, Yamauchi T11, Goh BC12. Phase I and biomarker

Genomic and Functional Analysis of the E3 Ligase PARK2 in Glioma (Cancer Res, May 2015)

References Lin DC1, Xu L2, Chen Y2, Yan H3, Hazawa M2, Doan N4, Said JW4, Ding LW2, Liu LZ2, Yang H2, Yu S5, Kahn M6, Yin D7, Koeffler HP8. Genomic and Functional Analysis of the E3 Ligase PARK2 in Glioma. Cancer Res. 2015 May 1;75(9):1815-27. PMID: 25877876. [PubMed] [Read by QxMD]